TP53 and breast cancer: Transcription of miR-4673 altered cell cycle function in breast cancer [127] and neurogenic [128] cells, involving indirect regulation of Notch function alongside β-catenin and p53, and this has been linked to loss of mitochondrial membrane potential and ROS generation in human carcinoma cells through targeting 8-oxoguanine DNA glycosylase 1 [129].